macro

Palantir Shares Slip Despite Barclays’ $265 Price Target

Palantir shares fell 1.1% to $206.90 even after Barclays began coverage with an Overweight rating and a $265 target, implying further upside.

on the website stories appear 15 minutes after publication, in the api at once. connect the api →

what happened

According to GuruFocus, shares of Palantir Technologies were down about 1.1% at $206.90 at 12:20 p.m. EST. The decline came as analysts continued to show bullish interest in the artificial-intelligence software company serving businesses and government agencies.

Yahoo Finance reported that Barclays initiated coverage with an Overweight rating and a $265 price target. Goldman Sachs set a $230 target, implying a smaller potential gain. Neither estimate represents a promise of future performance.

Palantir’s second-quarter U.S. commercial revenue reached $764 million, while revenue from the U.S. government totaled $809 million. Combined, those operations accounted for about 81.3% of the company’s approximately $1.935 billion in total revenue.

The shares were trading 11.28% above the $185.92 GF Value estimate. To support that premium, Palantir will need to add contracts and turn deployments into recurring revenue without engineering costs rising at a similar pace. Growing sovereign demand could expand the opportunity, but repeatable and profitable growth remains the key test.

why it matters

The company’s revenue mix leaves investors focused on two demand channels: corporate adoption and government spending. The market is also watching whether new deployments generate durable revenue rather than merely increasing contract volume.

instruments

Palantir Technologies

sources

  1. Palantir Stocks Slip Despite Barclays' $265 AI Target — gurufocus.com, 12 October 2026 at 19:10 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

on the website stories appear 15 minutes after publication, in the api at once.

get stories in real time ↗

early access

join newsmetry

leave your work email and we will open your trial as soon as accounts launch.